Literature DB >> 20398034

Clinical characteristics and prognostic factors for primary appendiceal carcinoma.

Yoon Ho Ko1, Se Hoon Park, Chan-Kwon Jung, Hye Sung Won, Sook Hee Hong, Ji Chan Park, Sang Young Roh, In Sook Woo, Jin Hyoung Kang, Young Seon Hong, Jae Ho Byun.   

Abstract

AIM: Primary adenocarcinoma of the appendix is a rare malignancy. This study assessed prognostic factors affecting the clinical outcome in patients with appendiceal neoplasms.
METHODS: We performed a retrospective analysis of patients who had appendectomies between 1991 and 2007 at five centers in South Korea.
RESULTS: Overall 55 patients (19 men, 36 women, median age 61 years) were identified. Of these, 37 (67.3%) were mucinous adenocarcinomas, 14 (25.5%) were intestinal-type adenocarcinomas, and four (7.3%) were signet ring cell carcinomas. The distribution of stages was: 26 (47.3%) with localized disease, five (9.1%) with regional disease, and 24 (43.6%) with distant metastatic disease. The overall 3- and 5-year survival rates among all patients were 72.2% and 64.0%, respectively, with 20 deaths during the follow-up period. In a multivariate analysis, high histological grade (hazard ratio [HR]vs low grade 15.7; P = 0.001) and pathological stage (distant vs loco-regional, HR 6.2; P = 0.021) were independent predictors of overall survival. Of the 34 patients who underwent curative resections of primary appendiceal carcinomas, the 3- and 5-year disease-free survival rates were 66.4% and 53.3%, respectively. The recurrence rate was higher in patients with regional lymph node metastasis (HR vs node negative disease 23.4; P = 0.005) and high-grade tumors (HR vs low grade 6.3; P = 0.029). Additionally, a right hemicolectomy reduced the risk of recurrence (HR vs lesser procedures 0.05; P = 0.005).
CONCLUSION: High tumor grade and advanced stage were significantly predictive of poor survival outcome in patients with primary appendiceal carcinomas.

Entities:  

Mesh:

Year:  2010        PMID: 20398034     DOI: 10.1111/j.1743-7563.2010.01276.x

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  6 in total

Review 1.  Leptomeningeal Metastasis from Appendiceal Adenocarcinoma: Case Report and Literature Review.

Authors:  Ali Mahta; Ryan Y Kim; Paul T Fanta; Joshua D Lawson; Santosh Kesari
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Clinicopathologic and prognostic features in appendiceal malignancies: does tumor invasiveness matter?

Authors:  Kazım Şenol; Murat Ferhat Ferhatoğlu; Deniz Tihan
Journal:  Turk J Surg       Date:  2019-12-16

3.  Incidentally Discovered Adenocarcinoma in situ of the Appendix in a Young Woman.

Authors:  Noriaki Koizumi; Yasutoshi Murayama; Yoshiaki Kuriu; Masayoshi Nakanishi; Kazuma Okamoto; Yukihito Kokuba; Eigo Otsuji
Journal:  Case Rep Gastroenterol       Date:  2012-09-22

4.  A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor.

Authors:  Hiroaki Shibahara; Michiyo Higashi; Seiya Yokoyama; Karine Rousseau; Iwao Kitazono; Masahiko Osako; Hiroshi Shirahama; Yukie Tashiro; Yasuhiro Kurumiya; Michihiko Narita; Shingo Kuze; Hiroshi Hasagawa; Takehito Kato; Hitoshi Kubota; Hideaki Suzuki; Toshiyuki Arai; Yu Sakai; Norihiro Yuasa; Masahiko Fujino; Shinji Kondo; Yoshichika Okamoto; Tatsuyoshi Yamamoto; Takashi Hiromatsu; Eiji Sasaki; Kazuhisa Shirai; Satoru Kawai; Koutarou Hattori; Hideki Tsuji; Osamu Okochi; Masaki Sakamoto; Akinobu Kondo; Naomi Konishi; Surinder K Batra; Suguru Yonezawa
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

5.  Cerebral metastasis from a previously undiagnosed appendiceal adenocarcinoma.

Authors:  Antonio Biroli; Paolo Cipriano Cecchi; Susanne Pragal; Esther Hanspeter; Andreas Schwarz
Journal:  Case Rep Oncol Med       Date:  2012-11-01

6.  Primary appendiceal mucinous adenocarcinoma mimicking bladder carcinoma: A case report and review of the literature.

Authors:  Kai Deng; Cheng-Qi Zhang; Guang-Li Wang; Wei Li
Journal:  Oncol Lett       Date:  2014-01-30       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.